Search Results - "ZIEMER, Mirjana"

Refine Results
  1. 1

    Atypical fibroxanthoma by Ziemer, Mirjana

    “…Summary Atypical fibroxanthoma (AFX) is a rare neoplastic disease of the skin. Since the term was coined in the early 1960s, the disease has been viewed in…”
    Get full text
    Journal Article
  2. 2

    Graft-versus-host disease of the skin and adjacent mucous membranes by Ziemer, Mirjana

    “…Summary Graft‐versus‐host disease is a complex multiorgan disease which mainly occurs in patients after allogeneic hematopoietic stem cell transplantation. The…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sensitivity and Specificity of Multiphoton Laser Tomography for In Vivo and Ex Vivo Diagnosis of Malignant Melanoma by Dimitrow, Enrico, Ziemer, Mirjana, Koehler, Martin Johannes, Norgauer, Johannes, König, Karsten, Elsner, Peter, Kaatz, Martin

    Published in Journal of investigative dermatology (01-07-2009)
    “…The incidence of malignant melanoma has shown a dramatic increase over the past three decades. Patient outcome and curability depend on early diagnosis. In…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies by Denisova, Evgeniya, Westphal, Dana, Surowy, Harald M., Meier, Friedegund, Hutter, Barbara, Reifenberger, Julia, Rütten, Arno, Schulz, Alexander, Sergon, Mildred, Ziemer, Mirjana, Brors, Benedikt, Betz, Regina C., Redler, Silke

    Published in Cancer gene therapy (01-06-2022)
    “…Malignant sweat gland tumours are rare, with the most common form being Eccrine porocarcinoma (EP). To investigate the mutational landscape of EP, we performed…”
    Get full text
    Journal Article
  7. 7

    Basal cell carcinoma with pulmonary and lymphatic metastases and TERT-promoter mutation by Hempel, Conrad, Bläker, Hendrik, Ziemer, Mirjana

    “…Basal cell carcinoma (BCC) is a common epithelial skin cancer. Other than cutaneous squamous cell carcinoma, apart from its aggressive loco-regional…”
    Get full text
    Journal Article
  8. 8

    Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations by Cosgarea, Ioana, Ugurel, Selma, Sucker, Antje, Livingstone, Elisabeth, Zimmer, Lisa, Ziemer, Mirjana, Utikal, Jochen, Mohr, Peter, Pfeiffer, Christiane, Pföhler, Claudia, Hillen, Uwe, Horn, Susanne, Schadendorf, Dirk, Griewank, Klaus G, Roesch, Alexander

    Published in Oncotarget (20-06-2017)
    “…Mucosal melanoma represents ~1% of all melanomas, frequently having a poor prognosis due to diagnosis at a late stage of disease. Mucosal melanoma differs from…”
    Get full text
    Journal Article
  9. 9
  10. 10

    In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas by Le Duc, Diana, Hentschel, Julia, Neuser, Sonja, Stiller, Mathias, Meier, Carolin, Jäger, Elisabeth, Abou Jamra, Rami, Platzer, Konrad, Monecke, Astrid, Ziemer, Mirjana, Markovic, Aleksander, Bläker, Hendrik, Lemke, Johannes R

    Published in European journal of human genetics : EJHG (01-03-2021)
    “…Pathogenic variants in TP53 have been classically thought to cause Li-Fraumeni syndrome (LFS), a cancer predisposition with high risks for various childhood-…”
    Get full text
    Journal Article
  11. 11

    Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome by Reschke, Robin, Zimmerlich, Stephanie, Döhring, Christine, Behre, Gerhard, Ziemer, Mirjana

    Published in Biomedicines (01-08-2022)
    “…Background: Patients with steroid-refractory intestinal acute graft-versus-host disease (aGvHD) and bronchiolitis obliterans syndrome (BOS) represent a…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Intralymphatic Histiocytosis. A Clinicopathologic Study of 16 Cases by REQUENA, Luis, EL-SHABRAWI-CAELEN, Laila, WALSH, Sarah N, SEGURA, Sonia, ZIEMER, Mirjana, HURT, Mark A, SANGÜEZA, Omar P, KUTZNER, Heinz

    Published in The American journal of dermatopathology (01-04-2009)
    “…Intralymphatic histiocytosis is a rare condition characterized by the presence of dilated lymphatic vessels containing aggregates of mononuclear histiocytes…”
    Get full text
    Journal Article
  15. 15

    IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids by Öz‐Arslan, Devrim, Rüscher, Wolfgang, Myrtek, Daniel, Ziemer, Mirjana, Jin, Yixin, Damaj, Bassam B., Sorichter, Stephan, Idzko, Marco, Norgauer, Johannes, Maghazachi, Azzam A.

    Published in Journal of leukocyte biology (01-08-2006)
    “…Lysophosphatidic acid (LPA) and sphingosine 1‐phosphate (S1P) are bioactive lipid mediators, which are known to play major roles in allergic reactions as well…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides by Escher, Niko, Kaatz, Martin, Melle, Christian, Hipler, Christina, Ziemer, Mirjana, Driescht, Dominik, Wollina, Uwe, von Eggeling, Ferdinand

    Published in Neoplasia (New York, N.Y.) (01-03-2007)
    “…Cutaneous T-cell lymphomas (CTCLs) are characterized by the recruitment of malignant T-cell clones, predominantly of the CD4+ T-helper subpopulation, into the…”
    Get full text
    Journal Article
  18. 18

    Rechallenge with checkpoint inhibitors in metastatic melanoma by Reschke, Robin, Ziemer, Mirjana

    “…Summary To date, there have been only few studies investigating rechallenge with checkpoint inhibitors in melanoma patients. Herein, we present the first…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Lysophosphatidic acid inhibits the cytotoxic activity of NK cells: involvement of Gs protein-mediated signaling by Lagadari, Mariana, Truta-Feles, Krisztina, Lehmann, Katja, Berod, Luciana, Ziemer, Mirjana, Idzko, Marco, Barz, Dagmar, Kamradt, Thomas, Maghazachi, Azzam A., Norgauer, Johannes

    Published in International immunology (01-06-2009)
    “…Lysophosphatidic acid (LPA) is an activator and chemoattractant of NK cells, which are critical members of the immunological tumor surveillance machinery…”
    Get full text
    Journal Article